Table 1.

Clinicopathological features of the 21 patients with SCC

Case No.	Gender/Age	Symptoms/duration (months)	Mass location	Gross	Size (cm)	TNM stage or metastasis	Therapy	Follow-up (months/status)
1	M/38	Progressive dysphagia/2	Middle 1/3	Medullary	4	PT3N0M0	S+C+R	48/DOD
2	F/62	progressive dysphagia/1	Middle 1/3	Medullary	3	PT2N1M0 IIb	S+C+R	71/DOD
3	M/62	progressive dysphagia/3	Lower 1/3	Medullary	1.5	PT2N2M0	S	5/DOD
4	M/57	dysphagia/10 days	Lower 1/3	Medullary	1.2	PT2N0M0	S+C	46/alive
5	M/51	dysphagia/1	Upper 1/3	mushroom-like	4	PT3N0M0	S+R	3/DOD
6	M/50	retrosternal complaint/9	Middle 1/3	Medullary	4	PT3N1M1 IV	S+C	13/DOD
7	M/47	dysphagia/2	Middle 1/3	Medullary	10	PT2N0M0	S	3/DOD
8	M/43	progressive dysphagia/3	Lower 1/3	Medullary	7	T4N2M1 IV	S+C	29/DOD
9	F/47	dysphagia/3	Middle 1/3	Medullary	4	PT3N1M0 II	S+C	5/DOD
10	M/45	dysphagia/2 months	Middle 1/3	Medullary	13	PT4N1M0 III	S+C	3/DOD
11	M/68	dysphagia/1	Lower 1/3	Medullary	5	PT2N1M0 II	S+C	15/DOD
12	F/52	dysphagia/2	Lower 1/3	Medullary	3	CT4N1M0	NT	7/DOD
13	M/46	progressive dysphagia/2	Lower 1/3	Medullary	15.5	liver metastasis	C	12/DOD
14	F/63	husk/2 and dysphagia/1	Middle 1/3	Medullary	5.5	thyroid metastasis	C	9/alive
15	M/57	Retrosternal complaint/1	Middle 1/3	Medullary	1.7	liver metastasis	C+R	15/DOD
16	F/76	progressive dysphagia/1	Middle 1/3	Medullary	6	NR	NT	5/DOD
17	M/43	dysphagia and retrosternal pain/2	Middle 1/3	Medullary	3.5	PT3N1M0	S+R	32/DOD
18	M/76	dysphagia/1	Middle 1/3	Ulceration	5	NR	R	28/DOD
19	M/73	Retrosternal complaint/3	Lower 1/3	Medullary	8	PT2N0M0 IIa	C+R	15/DOD
20	M/70	Retrosternal complaint/4	Lower 1/3	Ulceration	9	NR	C+R	13/alive
21	M/54	dysphagia/4	Middle 1/3	Medullary	8	PT3N1M0	C+R	8/DOD

NR, no record; NT, no treatment; S, Resection; C, Chemotherapy; R, Radiotherapy; DOD, Death of disease.